Publications by authors named "Matthew Seavey"

Claim this Profile
S
Secreted heat shock protein gp96-Ig and OX40L-Fc combination vaccine enhances SARS-CoV-2 Spike (S) protein-specific B and T cell immune responses.
Laura Padula, Eva Fisher, Katelyn Rivas, Kristin Podack, Daniela Frasca, Matthew M Seavey

Vaccine X· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of SARS-CoV-2 Protein S-Specific CD8+ T Cells in the Lungs of gp96-Ig-S Vaccinated Mice.
Eva Fisher, Laura Padula, Kristin Podack, Katelyn O'Neill, Matthew M Seavey

Front Immunol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiangiogenesis immunotherapy induces epitope spreading to Her-2/neu resulting in breast tumor immunoediting.
Matthew M Seavey, Yvonne Paterson

Breast Cancer (Dove Med Press)· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ubiquitin-like protein, ISG15, is a novel tumor-associated antigen for cancer immunotherapy.
Laurence M Wood, Zhen-Kun Pan, Matthew M Seavey, Geetha Muthukumaran, Yvonne Paterson

Cancer Immunol Immunother· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The many faces of Janus kinase.
Matthew M Seavey, Pawel Dobrzanski

Biochem Pharmacol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic efficacy of CEP-33779, a novel selective JAK2 inhibitor, in a mouse model of colitis-induced colorectal cancer.
Matthew M Seavey, Lily D Lu, Kristine L Stump, Nate H Wallace, William Hockeimer

Mol Cancer Ther· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel, orally active, proteasome inhibitor, delanzomib (CEP-18770), ameliorates disease symptoms and glomerulonephritis in two preclinical mouse models of SLE.
Matthew M Seavey, Lily D Lu, Kristine L Stump, Nate H Wallace, Bruce A Ruggeri

Int Immunopharmacol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2.
Lily D Lu, Kristine L Stump, Nate H Wallace, Pawel Dobrzanski, Cynthia Serdikoff, Matthew M Seavey

J Immunol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105.
Laurence M Wood, Zhen-Kun Pan, Patrick Guirnalda, Peter Tsai, Matthew Seavey

Cancer Immunol Immunother· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Animal models of systemic lupus erythematosus (SLE) and ex vivo assay design for drug discovery.
Matthew M Seavey, Lily D Lu, Kristine L Stump

Curr Protoc Pharmacol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis.
Kristine L Stump, Lily D Lu, Pawel Dobrzanski, Cynthia Serdikoff, Diane E Gingrich, Matthew M Seavey

Arthritis Res Ther· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel method of monitoring trace cytokines and activated STAT molecules in the paws of arthritic mice using multiplex bead technology.
Lily D Lu, Kristine L Stump, Matthew M Seavey

BMC Immunol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An anti-vascular endothelial growth factor receptor 2/fetal liver kinase-1 Listeria monocytogenes anti-angiogenesis cancer vaccine for the treatment of primary and metastatic Her-2/neu+ breast tumors in a mouse model.
Matthew M Seavey, Paulo C Maciag, Nada Al-Rawi, Duane Sewell, Yvonne Paterson

J Immunol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estradiol-induced vaginal mucus inhibits antigen penetration and CD8(+) T cell priming in response to intravaginal immunization.
Matthew M Seavey, Tim R Mosmann

Vaccine· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer immunotherapy using Listeria monocytogenes and listerial virulence factors.
Laurence M Wood, Patrick D Guirnalda, Matthew M Seavey, Yvonne Paterson

Immunol Res· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel human Her-2/neu chimeric molecule expressed by Listeria monocytogenes can elicit potent HLA-A2 restricted CD8-positive T cell responses and impact the growth and spread of Her-2/neu-positive breast tumors.
Matthew M Seavey, Zhen-Kun Pan, Paulo C Maciag, Anu Wallecha, Sandra Rivera

Clin Cancer Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature.
Paulo Cesar Maciag, Matthew M Seavey, Zhen-Kun Pan, Soldano Ferrone, Yvonne Paterson

Cancer Res· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoregulation of fetal and anti-paternal immune responses.
Matthew M Seavey, Tim R Mosmann

Immunol Res· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paternal antigen-bearing cells transferred during insemination do not stimulate anti-paternal CD8+ T cells: role of estradiol in locally inhibiting CD8+ T cell responses.
Matthew M Seavey, Tim R Mosmann

J Immunol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural correlates of a functional streptokinase antigenic epitope: serine 138 is an essential residue for antibody binding.
Behnaz Parhami-Seren, Matthew Seavey, Jolanta Krudysz, Panayota Tsantili

J Immunol Methods· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis